Boston Scientific vs Cigna Group

Boston Scientific (BSX), health care, and Cigna Group (CI), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Cigna Group is worth $78.5B on the stock market and Boston Scientific $62.7B: Cigna Group is valued at 25% more. Boston Scientific trades at 18.2 times earnings and Cigna Group at 13.1; operating margins in their latest fiscal years were 18.0% and 3.35%. Over the past year Boston Scientific's share price has moved -56.0% and Cigna Group's +10.1%.

Key facts

Boston Scientific market value
$62.7B
Cigna Group market value
$78.5B
Boston Scientific P/E
18.2
Cigna Group P/E
13.1
Boston Scientific revenue
$20.1BFY to 2025-12-31
Cigna Group revenue
$274.9BFY to 2025-12-31
Superinvestors holding both
4

Market values as of .

Boston Scientific vs Cigna Group: every measure side by side
Measure Boston Scientific Cigna Group
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$62.7Blower$78.5Bhigher
Revenue$20.1Blower$274.9Bhigher
Earnings$2.9Blower$6Bhigher
Employees59,000lower65,669higher
Total assets$43.7Blower$157.9Bhigher
Valuation
P/E18.2higher13.1lower
P/S3.1higher0.3lower
P/B2.4higher1.8lower
Dividend yield0.00%lower2.06%higher
Profitability
Operating margin18.0%higher3.35%lower
Balance sheet
Net assets$24.2Blower$41.7Bhigher
Total liabilities$19.2Blower$116Bhigher
Total debt$11.4Blower$31.5Bhigher
Cash on hand$2Blower$7.7Bhigher
Price change
Today-1.05%lower-0.80%higher
1 year-56.0%lower+10.1%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Boston Scientific / Cigna Group). Who owns BSX · Who owns CI

Further comparisons

Learn

Questions and answers

Which is bigger, Boston Scientific or Cigna Group?

By market value, Cigna Group is the larger: $78.5B against $62.7B for Boston Scientific. By revenue in its latest fiscal year, Cigna Group is the larger: $274.9B against $20.1B for Boston Scientific.

Which has the higher P/E ratio?

Boston Scientific: 18.2, against 13.1 for Cigna Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Boston Scientific: 18.0%, against 3.35% for Cigna Group. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Cigna Group: 2.06%, against 0.00% for Boston Scientific. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Cigna Group: $31.5B, against $11.4B for Boston Scientific. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Boston Scientific and Cigna Group?

In their latest 13F filings, Louis Bacon, John Overdeck and David Siegel (founders), Dodge & Cox team and Larry Robbins hold both.

Cite this page

Funkfolio, “Boston Scientific vs Cigna Group”, data as of 17 November 2026. https://funkfolio.com/compare/bsx-vs-ci

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.